United Therapeutics | UTHR - Gross Profit On Sales


United Therapeutics reported $315.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Amarin USD 23.17M 961K Dec/2025
Ardelyx USD 89.66M 24.7M Mar/2026
Baxter International USD 891M 314M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
BioCryst Pharmaceuticals USD 153.05M 4.16M Dec/2025
Biogen USD 1.82B 169.5M Mar/2026
BioMarin Pharmaceutical USD 571.21M 141.8M Mar/2026
Gilead Sciences USD 5.52B 791M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Insmed USD 256.46M 38.78M Mar/2026
Ionis Pharmaceuticals USD 243M 48M Mar/2026
J&J USD 18.55B 1.31B Jun/2026
Lexicon Pharmaceuticals USD 5.29M 8.88M Dec/2025
Moderna USD -566M 792M Mar/2026
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 11.04B 1.24B Mar/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026
United Therapeutics USD 315.5M 286.6M Dec/2025
Vertex Pharmaceuticals USD 2.6B 121.7M Mar/2026